Results 111 to 120 of about 3,154,947 (221)

Tumor immunology meets oncology (TIMO) XVI, July 07-09 2022 in Halle/Saale, Germany. [PDF]

Cancer Immunol Immunother, 2023
Seliger B.
europepmc   +1 more source

Dendritic Cells in Cancer Immunology and Immunotherapy

Cancers
Simple Summary Although immune check point inhibitors have been established as a new paradigm in cancer treatment, they have shown no clinical benefit in immune excluded or dessert tumors.
L. Hato, Angel Vizcay, I. Eguren, J. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, S. Inogés, Ascensión López Díaz de Cerio, Marta Santisteban   +9 more
semanticscholar   +1 more source

MHC class I/II deficient NOG mice are useful for analysis of human T/B cell responses for human tumor immunology research [PDF]

, 2013
Tomonori Yaguchi, Asuka Kobayashi, Ikumi Katano, Yuyo Ka, Mamoru Ito, Yutaka Kawakami   +5 more
openalex   +1 more source

Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances [PDF]

, 2013
Bridget P. Keenan, Elizabeth M. Jaffee, Todd D. Armstrong   +2 more
openalex   +1 more source

Tumor Immunology, toward a Success Story? [PDF]

, 2015
Catherine Sautès‐Fridman
openalex   +1 more source

Radiotherapy and immunology

Journal of Experimental Medicine
The majority of cancer patients receive radiotherapy. Wang et al. review preclinical and clinical data related to the importance of immune responses to radiotherapy-induced anti-tumor effects, as well as blockade of immune checkpoints PD-1/PD-L1 and/or ...
Liangliang Wang, C. Lynch, S. Pitroda, András Piffkó, Kaiting Yang, Amy K Huser, H. Liang, R. Weichselbaum   +7 more
semanticscholar   +1 more source

Evodiamine inhibits colorectal cancer cell stemness by disturbing ubiquitin specific protease 4 mediated SOX9 stabilization

Discover Oncology
Colorectal cancer (CRC) is the third most common cancer and the second most deadly cancer worldwide. It is of great importance to explore new mechanisms and therapeutic targets.
Siqi Chen, Jinfeng Yang, Guangying Qi, Jiawei Zhao, Yujing Chen, Xiaotong Guo, Juzheng Zhang, Jinfeng Gan, Zhiyuan Jian, Jiamin Jin   +9 more
doaj   +1 more source

Studies on Immunology of the Transprantable Tumor (Yoshida Sarcoma)

, 1958
Keiichi Kamishirado
openalex   +2 more sources

Synergism of PDL/PD1 and IL33/ST2 Axis in Tumor Immunology [PDF]

, 2019
Marina Jovanović, Nevena Gajović, Miodrag L. Lukić, Ana Popović, Ivan Jovanović   +4 more
openalex   +1 more source

Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance. [PDF]

Front Immunol, 2022
Ganjoo S, Puebla-Osorio N, Nanez S, Hsu E, Voss T, Barsoumian H, Duong LK, Welsh JW, Cortez MA.   +8 more
europepmc   +1 more source